Industry Overview - The micro-infusion pump is a key device in modern healthcare, enhancing the safety and efficiency of clinical treatments through precise drug delivery and intelligent control [1][10] - The market size of China's micro-infusion pump industry reached 2.477 billion yuan in 2019 and is projected to grow to 3.356 billion yuan by 2024, with a compound annual growth rate (CAGR) of 6.3% [1][10] - The increasing demand for chronic disease management and aging population is driving the expansion of the micro-infusion pump market [1][10] Market Dynamics - The population aged 65 and above in China is expected to rise from 177.67 million in 2019 to 219.69 million by 2024, reflecting a CAGR of 4.3% [4] - The growing number of chronic disease patients, such as those with cancer and diabetes, is increasing the demand for precise medical devices, providing significant growth opportunities for the micro-infusion pump industry [4] Industry Chain - The upstream of the micro-infusion pump industry includes raw materials like plastics and metals, as well as components such as motors, pump bodies, and controllers [8] - The midstream involves the manufacturing of micro-infusion pumps, while the downstream encompasses applications in various fields, including chemistry, biology, and medicine [8] Competitive Landscape - The industry is transitioning from "import dependence" to "domestic substitution," with international manufacturers maintaining dominance in the high-end market due to their technological advantages [12] - Domestic companies are rapidly emerging through policy support, cost control, and innovative applications [12] Key Companies - Major players in the micro-infusion pump industry include Mindray Medical (300760), Huayang Intelligent (301502), Micron Medical (00853), Yuyue Medical (002223), and Zhonghong Medical (300981) [2][12] - Mindray Medical reported a revenue of 8.237 billion yuan in 2024, a year-on-year decrease of 12.12%, with a net profit of 2.629 billion yuan, down 16.81% [13] - Huayang Intelligent achieved a revenue of 0.37 billion yuan in precision injection devices in 2024, reflecting a year-on-year decline of 36.17% [15] Development Trends - The future of the micro-infusion pump industry is characterized by the integration of intelligent control technologies and AI algorithms, enhancing precision and reducing human error [17] - There is a push towards the development of portable micro-infusion pumps, which are lightweight and suitable for various medical scenarios, including home care [18] - The industry is expected to continue expanding, driven by advancements in technology and increasing demand across multiple sectors [20]